Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use – and failure to do so may be grounds for compensation. Our lawyers are operating hard to obtain these hurt by the drug the compensation they’re entitled to.
Although bleeding is really a frequent complication related with anticoagulants, it has been alleged that Xarelto is much more dangerous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, in the occasion of an emergency, sufferers may possibly be at risk for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.
In case you or possibly a loved one suffered a serious bleeding event after taking Xarelto, you might have legal recourse. For far more data, make contact with us these days to have your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and xareltonewstoday.s3.amazonaws.com Janssen for past and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral expenses. Additionally, they’re in search of punitive damages, which are typically awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for much more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.